BioCardia

Bio Cardia

Biotechnology, 320 Soquel Way, Sunnyvale, California, 94085, United States, 11-50 Employees

biocardia.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 65********

Who is BIOCARDIA

We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia is developing proprietary compreh...

Read More

map
  • 320 Soquel Way, Sunnyvale, California, 94085, United States Headquarters: 320 Soquel Way, Sunnyvale, California, 94085, United States
  • 2002 Date Founded: 2002
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BIOCARDIA

BioCardia Org Chart and Mapping

Employees

Awais Jan

Senior QA Specialist

Larry Lobacz

Regional Account Manager

Mandy Kaur

Clinical Trial Associate

Mark Tale

Sr. Manufacturing Technician

Tom Le

Associate Director of Quality Engineering and Compliance

Julie Phillips

Associate Director of Cell Therapy and Diagnostic R&D

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BioCardia

Answer: BioCardia's headquarters are located at 320 Soquel Way, Sunnyvale, California, 94085, United States

Answer: BioCardia's phone number is 65********

Answer: BioCardia's official website is https://biocardia.com

Answer: BioCardia's revenue is $1 Million to $5 Million

Answer: BioCardia's SIC: 2836

Answer: BioCardia's NAICS: 325414

Answer: BioCardia has 11-50 employees

Answer: BioCardia is in Biotechnology

Answer: BioCardia contact info: Phone number: 65******** Website: https://biocardia.com

Answer: We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its CardiAMPTM and CardiALLOTM therapies. Clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. These programs are enabled by the Company's HelixTM transendocardial delivery systems and Morph vascular access products, which are partnered to enable other promising biotherapeutic programs.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access